#USA #Board of Directors #Portland, Oregon #Araceli Biosciences #Christine Tsingos

Araceli Biosciences Appoints Christine A. Tsingos to Board of Directors

In an exciting development, Araceli Biosciences has announced the appointment of Christine A. Tsingos to its Board of Directors effective April 16, 2026. With a rich background in public company operations and finance, Tsingos is set to contribute significantly as the company enters a new phase of growth.

Tsingos brings over 30 years of extensive experience in financial management, corporate governance, and strategic planning. Previously serving as the Executive Vice President and Chief Financial Officer at Bio-Rad Laboratories from 2002 to 2019, she played a pivotal role in the company’s sustained growth and strategic expansion initiatives. Her expertise spans critical areas including capital strategy, investor relations, mergers and acquisitions, and information technology.

Bill Cortelyou, the Chairman of the Board at Araceli Biosciences, commented on Tsingos’s appointment, stating, “Christine’s strong acumen in finance and corporate governance comes at a crucial time in Araceli’s growth. Her experience in elevating bioscience companies and directing long-term value creation will fortify our board’s efforts to support disciplined growth and the next stage of scaling.”

As Araceli navigates its transition towards AI-powered pharmaceutical research, Tsingos’s industry insights will be instrumental. CEO Matt Beaudet emphasized the significance of her experience in embedding systems into modern laboratory infrastructures, noting, “Christine’s background in helping companies evolve from standalone tools to integrated systems aligns with our growth trajectory.”

Outside of her role at Araceli, Tsingos is an active board member for Envista Holdings and Varex Imaging Corporation, and has previously served on the boards of Onto Innovation and Telesis Bio. Her academic credentials include a B.A. in International Studies from the American University and an MBA in International Business from the George Washington University. In recognition of her contributions, she was awarded the title of “Bay Area CFO of the Year” by the San Francisco Business Times in 2010.

Expressing her enthusiasm for joining Araceli, Tsingos stated, “Araceli has developed strong momentum in a short time, reflecting both the strength of its technology and a clear market need. The focus now is on building the foundation to support this growth on a large scale, and I am excited to be a part of it.”

About Araceli Biosciences

Araceli Biosciences is at the forefront of advancing biological research through ultra-high-throughput imaging solutions, helping researchers generate meaningful data and expedite decision-making in drug discovery and bioscience research protocols.

For more information, please contact:
Don Weldon
VP of Marketing
[Email Address]